These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24931806)

  • 1. An observational analysis of provider adherence to AUA guidelines on the management of benign prostatic hyperplasia.
    Auffenberg GB; Gonzalez CM; Wolf JS; Clemens JQ; Meeks W; McVary KT
    J Urol; 2014 Nov; 192(5):1483-8. PubMed ID: 24931806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
    Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
    J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to Agency for Health Care Policy and Research guidelines for benign prostatic hyperplasia.
    Hood HM; Burgess PA; Holtgrewe HL; Fleming B; Mebust W; Connolly RP
    J Urol; 1997 Oct; 158(4):1417-21. PubMed ID: 9302134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy: revisited.
    Juliao AA; Plata M; Kazzazi A; Bostanci Y; Djavan B
    Curr Opin Urol; 2012 Jan; 22(1):34-9. PubMed ID: 22123290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.
    Hollingsworth JM; Hollenbeck BK; Daignault S; Kim SP; Wei JT
    J Urol; 2009 Nov; 182(5):2410-4. PubMed ID: 19765742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multifaceted Assessment of Benign Prostatic Hyperplasia Practice and AUA Guideline Adherence.
    Welliver C; MacLachlan LS; Riggs S; Kukreja JB; Miles-Thomas J
    Urol Pract; 2024 Nov; 11(6):950-955. PubMed ID: 39196671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the impact of CTMH guidelines on the management of benign prostatic hyperplasia].
    Lebdai S; Rahmène Azzouzi A; Delongchamps NB; Benchikh A; Campeggi A; Cornu JN; Dumonceau O; Faix A; Fourmarier M; Haillot O; Lukacs B; Mathieu R; Misrai V; Robert G; de La Taille A; Descazeaud A
    Prog Urol; 2015 Jan; 25(1):47-53. PubMed ID: 25453357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk of treatment for benign prostatic hyperplasia in Japanese men: a 15-year longitudinal community-based study.
    Fukuta F; Masumori N; Mori M; Tsukamoto T
    Int J Urol; 2013 Jan; 20(1):100-6. PubMed ID: 23106204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian guidelines for the management of benign prostatic hyperplasia.
    Nickel JC; Herschorn S; Corcos J; Donnelly B; Drover D; Elhilali M; Goldenberg L; Grantmyre J; Laroche B; Norman R; Piercy B; Psooy K; Steinhoff G; Trachtenberg J; Saad F; Tanguay S; ;
    Can J Urol; 2005 Jun; 12(3):2677-83. PubMed ID: 16011814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?
    Kaplan SA; Olsson CA; Te AE
    J Urol; 1996 Jun; 155(6):1971-4. PubMed ID: 8618299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translation of benign prostatic hyperplasia guidelines into clinical practice.
    Gravas S; Tzortzis V; Melekos MD
    Curr Opin Urol; 2008 Jan; 18(1):56-60. PubMed ID: 18090491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study.
    Donovan JL; Peters TJ; Neal DE; Brookes ST; Gujral S; Chacko KN; Wright M; Kennedy LG; Abrams P
    J Urol; 2000 Jul; 164(1):65-70. PubMed ID: 10840426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population.
    Strope SA; Elliott SP; Saigal CS; Smith A; Wilt TJ; Wei JT;
    Urology; 2011 Jul; 78(1):3-9. PubMed ID: 21601254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The American Urological Association 2003 guideline on management of benign prostatic hyperplasia: a Canadian opinion.
    Nickel JC; Saad F
    Can J Urol; 2004 Apr; 11(2):2186-93. PubMed ID: 15182407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States.
    Clemens JQ; Goldman HB; Zou KH; Luo X; Russell D; Chapman DS; Esinduy CB; Anger JT
    J Urol; 2016 Jul; 196(1):173-8. PubMed ID: 26872842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.
    Roehrborn CG; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Brown BT; McVary KT; Te AE; Gholami SS; Rashid P; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rukstalis DB
    J Urol; 2013 Dec; 190(6):2161-7. PubMed ID: 23764081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lost to follow-up in high level evidence-based studies related to the surgical management of lower urinary tract symptoms secondary to benign prostatic enlargement: does it matter?
    Ou R; Zimmern P
    Neurourol Urodyn; 2011 Nov; 30(8):1416-21. PubMed ID: 21826723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.
    Tsukamoto T; Masumori N; Rahman M; Crane MM
    Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.